| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alkylphosphocholines: new agents with antineoplastic properties
|
Unger, C.
|
|
1987
|
|
3-4 |
p. 305-
1 p.
|
artikel
|
| 2 |
Amelioration of adriamycin toxicity through modification of drug-DNA binding properties
|
Israel, Mervyn
|
|
1987
|
|
3-4 |
p. 163-167
5 p.
|
artikel
|
| 3 |
Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compounds
|
Herman, Eugene H.
|
|
1987
|
|
3-4 |
p. 225-229
5 p.
|
artikel
|
| 4 |
Announcement
|
|
|
1987
|
|
3-4 |
p. 421-422
2 p.
|
artikel
|
| 5 |
Antiemetic properties of the 5HT3-receptor antagonist, gr38032f
|
Stables, R.
|
|
1987
|
|
3-4 |
p. 333-336
4 p.
|
artikel
|
| 6 |
Biodistribution of methotrexate-monoclonal antibody conjugates and complexes: experimental and clinical studies
|
Pimm, M.V.
|
|
1987
|
|
3-4 |
p. 411-420
10 p.
|
artikel
|
| 7 |
Biologic considerations for drug targeting in cancer patients
|
Welch, Danny R.
|
|
1987
|
|
3-4 |
p. 351-358
8 p.
|
artikel
|
| 8 |
Bone marrow transplantation
|
Barrett, A.J.
|
|
1987
|
|
3-4 |
p. 203-213
11 p.
|
artikel
|
| 9 |
Clinically useful doxorubicin analogues
|
Arcamone, F.
|
|
1987
|
|
3-4 |
p. 159-161
3 p.
|
artikel
|
| 10 |
Cost-effectiveness of cancer chemotherapy: risks/benefit ratio—socio-economic and ethical considerations
|
Macdonald, E.A.
|
|
1987
|
|
3-4 |
p. 345-350
6 p.
|
artikel
|
| 11 |
Current status of oxazaphosphorine analogue development
|
Hilgard, P.
|
|
1987
|
|
3-4 |
p. 187-192
6 p.
|
artikel
|
| 12 |
Daunomycin- and adriamycin-N-(2-hydroxypropyl)methacrylamide copolymer conjugates; toxicity reduction by improved drug-delivery
|
Seymour, L.W.
|
|
1987
|
|
3-4 |
p. 319-327
9 p.
|
artikel
|
| 13 |
Estrophilic cisplatin derivatives
|
Engel, J.
|
|
1987
|
|
3-4 |
p. 275-283
9 p.
|
artikel
|
| 14 |
Foreword
|
Hellmann, K.
|
|
1987
|
|
3-4 |
p. 157-
1 p.
|
artikel
|
| 15 |
Free radical modulation by N-substituted dehydroalanines, a new way to improve therapeutic activity of anticancer drugs
|
Buc-Calderon, P.
|
|
1987
|
|
3-4 |
p. 379-382
4 p.
|
artikel
|
| 16 |
Improvement of therapeutic index in gastrointestinal cancer
|
Herrmann, Richard
|
|
1987
|
|
3-4 |
p. 259-262
4 p.
|
artikel
|
| 17 |
Improving the therapeutic index of systemic therapy with special emphasis on cisplatin and carboplatin
|
Carter, Stephen K.
|
|
1987
|
|
3-4 |
p. 179-185
7 p.
|
artikel
|
| 18 |
in vitro screening of new drugs and analogues—specificity and selectivity
|
Hill, Bridget T.
|
|
1987
|
|
3-4 |
p. 197-202
6 p.
|
artikel
|
| 19 |
Liblomycin, a new analogue of bleomycin
|
Takahashi, Katsutoshi
|
|
1987
|
|
3-4 |
p. 169-177
9 p.
|
artikel
|
| 20 |
Limb perfusion
|
Westbury, G.
|
|
1987
|
|
3-4 |
p. 257-
1 p.
|
artikel
|
| 21 |
Mesna and oxazaphosphorine cancer chemotherapy
|
Shaw, I.C.
|
|
1987
|
|
3-4 |
p. 359-364
6 p.
|
artikel
|
| 22 |
Mitoxantrone: an active, new antitumor agent with an improved therapeutic index
|
Saletan, S.
|
|
1987
|
|
3-4 |
p. 297-303
7 p.
|
artikel
|
| 23 |
Mitozantrone therapeutic index improvement by gangliosides
|
Hellmann, K.
|
|
1987
|
|
3-4 |
p. 373-378
6 p.
|
artikel
|
| 24 |
Monoclonal antibody drug conjugates for site-directed cancer chemotherapy: preclinical pharmacology and toxicology studies
|
Johnson, I.S.
|
|
1987
|
|
3-4 |
p. 193-196
4 p.
|
artikel
|
| 25 |
N′-(2-chloroethyl)-N′-nitrosocarbamoyl amino acid derivatives of steroid hormones
|
Eisenbrand, G.
|
|
1987
|
|
3-4 |
p. 285-290
6 p.
|
artikel
|
| 26 |
Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (mesna): experimental results
|
Kempf, S.R.
|
|
1987
|
|
3-4 |
p. 365-372
8 p.
|
artikel
|
| 27 |
New cytostatics with experimentally different toxic profiles
|
Berger, M.R.
|
|
1987
|
|
3-4 |
p. 307-317
11 p.
|
artikel
|
| 28 |
Radiochemotherapy with 125I-5-iodo-2-deoxyuridine
|
Bagshawe, K.D.
|
|
1987
|
|
3-4 |
p. 397-399
3 p.
|
artikel
|
| 29 |
Randomized study of intrahepatic (H) versus systemic (S) infusion of fluorodeoxyuridine (FUDR) in patients with liver metastases from colorectal carcinoma (CRC)
|
Kemeny, N.
|
|
1987
|
|
3-4 |
p. 245-
1 p.
|
artikel
|
| 30 |
Reduction in doxorubicin toxicity following liposomal delivery
|
Sells, R.A.
|
|
1987
|
|
3-4 |
p. 383-387
5 p.
|
artikel
|
| 31 |
Reduction of pulmonary toxicity
|
Scheulen, M.E.
|
|
1987
|
|
3-4 |
p. 231-243
13 p.
|
artikel
|
| 32 |
Safer cancer chemotherapy using a kinetically-based experimental approach: higher dose intensity with reduced toxicity
|
Price, L.A.
|
|
1987
|
|
3-4 |
p. 215-223
9 p.
|
artikel
|
| 33 |
Second malignancies—risk reduction
|
Petru, E.
|
|
1987
|
|
3-4 |
p. 337-343
7 p.
|
artikel
|
| 34 |
Significance of control of the side-effects of chemotherapy treatment
|
Spittle, M.F.
|
|
1987
|
|
3-4 |
p. 329-331
3 p.
|
artikel
|
| 35 |
Some procedures to reduce cis-platinum toxicity reduce antitumour activity
|
Aamdal, Steinar
|
|
1987
|
|
3-4 |
p. 389-395
7 p.
|
artikel
|
| 36 |
Structural modifications of the vinca alkaloids
|
Johnson, I.S.
|
|
1987
|
|
3-4 |
p. 407-410
4 p.
|
artikel
|
| 37 |
Studies on experimental liver infusion and additional systemic detoxification
|
Friedl, P.
|
|
1987
|
|
3-4 |
p. 247-255
9 p.
|
artikel
|
| 38 |
The search for more active and less toxic mitomycin and etoposide analogs
|
Stringfellow, Dale A.
|
|
1987
|
|
3-4 |
p. 291-295
5 p.
|
artikel
|
| 39 |
The value of markers in fine tuning of chemotherapy
|
Milford Ward, A.
|
|
1987
|
|
3-4 |
p. 401-405
5 p.
|
artikel
|
| 40 |
Treatment toxicity reduction: breast cancer
|
Possinger, K.
|
|
1987
|
|
3-4 |
p. 263-274
12 p.
|
artikel
|
Tijdschrift beschrijving